Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

For patients with metastatic HR+/HER2— breast cancer, there were various trials to have come out of ASCO 2025 that are worth keeping your eye on.

Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance (NOC) for KISQALI® (ribociclib ...

University of Cambridge study shows how LLM GPT-4 can generate novel combinations of drugs not typically used to treat cancer ...

Emerging research continues to spotlight the potential role of diet in cancer prevention, with olive oil—a cornerstone of the Mediterranean diet&mdas | Drug Discovery And Development ...

Actor Aruna Irani recently revealed she kept her breast cancer diagnosis private. While she initially avoided chemotherapy and opted for medicines, she had to undergo chemo when the cancer returned in ...

Tumors are complex systems characterized by variations across genetic, transcriptomic, phenotypic, and microenvironmental ...

BAMF Health in Grand Rapids has launched a study to identify markers for targeted breast cancer therapies using PET scans.

I maintain a Buy rating on Zymeworks Inc. stock due to platform promise and upcoming catalysts. However, click for why I am ...

MacMillan has been named a Distinguished Scholar in the Princeton Branch of the Ludwig Institute for Cancer Research, which ...